May 8, 2026 08:45AM
Mar 27, 2026 06:46AM
Mar 25, 2026 05:30PM
Mar 19, 2026 11:00AM
Nov 12, 2025 04:23PM
Nov 12, 2025 08:15AM
Sep 8, 2025 08:30AM Atossa requests FDA meeting for endoxifen breast cancer drug development
Sep 8, 2025 08:30AM
Aug 29, 2025 09:00AM
Aug 12, 2025 09:46AM
Aug 12, 2025 08:30AM
Aug 1, 2025 09:00AM
May 13, 2025 05:31PM
May 13, 2025 08:00AM Atossa Therapeutics Announces First Quarter 2025 Financial Results and Provides a Corporate Update
May 2, 2025 09:00AM
Mar 26, 2025 06:52AM
Mar 25, 2025 08:00AM
Mar 20, 2025 09:13AM
Jan 23, 2025 08:15AM
Nov 13, 2024 06:54AM
Nov 12, 2024 08:30AM Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Aug 12, 2024 05:06PM
Aug 12, 2024 08:30AM
May 14, 2024 06:54AM
May 13, 2024 08:50AM
Apr 1, 2024 04:00PM
Nov 13, 2023 09:00AM
Sep 8, 2023 06:07AM Cantor Fitzgerald Starts Atossa Genetics (ATOS) at Overweight, 'Changing the Treatment Paradigm in Breast Cancer'
Aug 14, 2023 09:05AM
Aug 14, 2023 08:30AM
Aug 8, 2023 09:00AM
May 15, 2023 09:10AM
Mar 22, 2023 04:07PM
Mar 22, 2023 04:05PM
Nov 7, 2022 04:00PM Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
Aug 8, 2022 04:30PM
May 9, 2022 04:05PM
Feb 28, 2022 04:15PM
Nov 15, 2021 09:30AM
Aug 13, 2021 09:30AM
May 14, 2021 09:15AM
Mar 31, 2021 09:30AM Atossa Therapeutics Announces Year End 2020 Financial Results and Provides Corporate Update
Nov 13, 2020 09:30AM
Aug 13, 2020 09:30AM
May 13, 2020 09:30AM
Mar 26, 2020 08:00AM
Feb 3, 2020 05:33AM
Nov 13, 2019 08:00AM
Aug 13, 2019 01:26PM Atossa Genetics Announces Second Quarter 2019 Financial Results and Provides Company Update
May 13, 2019 05:21PM

1,198,612 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All